SCHEMBL19804773

SCHEMBL19804773

C/C=C(\C)C(=O)OCCc1cc(OCCO)ccc1-c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 4/20 0.43
CYP3A4 P08684 3/20 0.43
APP P05067 3/20 0.43
CYP2C9 P11712 3/20 0.43
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
CSF1R P07333 1/20 0.33
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP9 P14780 1/20 0.32
MMP14 P50281 1/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
S1PR1 P21453 2/20 0.32
S1PR3 Q99500 2/20 0.32
MOGAT2 Q3SYC2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19797072 0.88 FFAR4 (0.37) FFAR4CYP3A4APPCYP2C9S1PR1
SCHEMBL19804576 0.86 FFAR4 (0.48) FFAR4CYP3A4APPCYP2C9ALDH1A1
SCHEMBL19804634 0.84 FFAR4 (0.44) FFAR4CYP3A4APPCYP2C9ALDH1A1
SCHEMBL19804748 0.81 CYP3A4 (0.43) FFAR4CYP3A4APPCYP2C9CYP2D6
SCHEMBL19804784 0.80 FFAR4 (0.39) FFAR4CYP3A4APPCYP2C9ALDH1A1
SCHEMBL19804777 0.79 FFAR4 (0.45) FFAR4CYP3A4APPCYP2C9ALDH1A1
SCHEMBL19804148 0.78 FFAR4 (0.44) FFAR4CYP3A4APPCYP2C9ALDH1A1
SCHEMBL19804615 0.78 FFAR4 (0.39) FFAR4CYP3A4APPCYP2C9ALDH1A1
SCHEMBL19804822 0.78 FFAR4 (0.43) FFAR4CYP3A4APPCYP2C9ALDH1A1
SCHEMBL19804626 0.76 CYP3A4 (0.44) FFAR4CYP3A4APPCYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 FFAR4 1715/4885CYP3A4 2192/4885APP 325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.